Two new blood tests are now available through the Healius Pathology Network, providing GPs with additional information to support clinical decisions in two challenging patient groups.
Proteomics International's Promarker® products are based on the proteins found in individuals with a targeted clinical condition. Proteomics has developed a versatile platform technology for discovering proteins which strongly correlate (positively and/or negatively) with a clinical condition. By comparing blood or other biological samples taken from individuals with and without the condition, our team is able to produce a set of highly specific “biomarkers”. These biomarkers are biological signatures for that condition. When these data are combined with clinical factors in our proprietary clinical algorithm "Promarker Hub", our biomarker-based diagnostics enable clinicians with a window onto individual's unique biochemical activity.
The PromarkerD and PromarkerESO tests are now available via the Healius Pathology Network. Learn more about these tests below.
Proteomics International's Promarker® products are based on the proteins found in individuals with a targeted clinical condition. Proteomics has developed a versatile platform technology for discovering proteins which strongly correlate (positively and/or negatively) with a clinical condition. By comparing blood or other biological samples taken from individuals with and without the condition, our team is able to produce a set of highly specific “biomarkers”. These biomarkers are biological signatures for that condition. When these data are combined with clinical factors in our proprietary clinical algorithm "Promarker Hub", our biomarker-based diagnostics enable clinicians with a window onto individual's unique biochemical activity.
The PromarkerD and PromarkerESO tests are now available via the Healius Pathology Network. Learn more about these tests below.

